Term Sheet Anatomy
The term sheet is not a legally binding contract (save for confidentiality and exclusivity), but it sets the non-negotiable economic and control framework for the definitive documents.
Economic Terms
These terms dictate how money is distributed in a liquidity event. The primary levers are:
- Valuation (Pre-Money vs. Post-Money): The price of the company. Post-Money = Pre-Money + Investment.
- Liquidation Preference: Defines who gets paid first and how much. The standard is 1x non-participating. Anything else (e.g., 2x participating) is highly punitive to founders.
- Option Pool: Investors usually require the post-money option pool to be created pre-money, meaning the dilution is borne entirely by existing shareholders (the founders).
- Anti-Dilution: Protects investors in a down-round. "Broad-based weighted average" is standard; "Full Ratchet" is toxic.
Control Terms
These terms dictate who runs the company and who has veto power over major decisions.
- Board of Directors: Typically a 3 or 5 person board. (e.g., 2 Founders, 1 VC, 1 Independent).
- Protective Provisions: Veto rights for the preferred shareholders over actions like selling the company, changing the board size, or taking on debt.
- Drag-Along Rights: Forces minority shareholders to agree to a sale of the company if the majority (and the VC) agrees.
Common Mistakes
Founders often focus entirely on valuation and ignore control terms. A high valuation with punitive liquidation preferences (e.g. participating) and harsh protective provisions can result in founders losing control of the company and making zero money in a moderate exit.
FAQ
- Is a term sheet legally binding?
- Mostly no. The economic and control terms are non-binding. However, the confidentiality and exclusivity (no-shop) clauses are legally binding.
- How long is the exclusivity period?
- Typically 30 to 45 days. This gives the investor time to conduct due diligence without the founder shopping their offer to competitors.
Standard Market Terms (2024)
| Liquidation Pref | 1x Non-Participating |
| Anti-Dilution | Broad-based weighted avg |
| Option Pool | 10-15% (Post-Money) |
| Dividends | Non-cumulative |
| Pay-to-Play | Rare in early stage |
Source: Pitchbook NVCA Monitor Q1 2024. Based on 1,500+ analyzed deals.